How to Help Your Patients Find Foundayo in Stock: A Provider's Guide

When Foundayo (orforglipron) received FDA approval on April 1, 2026, prescribers across the country were ready to offer their patients a genuinely new option: the first no-restriction oral GLP-1 medication for weight management. The challenge? Within days of the approval, patient calls about pharmacy availability difficulties began flooding into provider offices.

This guide equips providers with a practical system for helping patients access Foundayo, from the moment you write the prescription through the first fill and beyond.

Step 1: Route the Prescription to LillyDirect Instead of a Retail Pharmacy

The single most impactful action you can take at the point of prescribing is to route the prescription to LillyDirect rather than your patient's usual retail pharmacy. Eli Lilly's direct pharmacy service, which launched shipping on April 6, 2026, has priority access to Foundayo inventory and has been the most reliable dispensing channel since launch.

LillyDirect details for prescribers:

• Pharmacy NPI: 1912889320
• NCPDP: 1574056
• Fulfillment partners: Prescryptive and Amazon Pharmacy
• Savings cards: Applied automatically for eligible patients
• Prior auth support: LillyDirect staff can assist with prior authorization paperwork

Step 2: Proactively Submit Prior Authorization at the Time of Prescribing

Most commercial insurance plans require prior authorization for Foundayo. Waiting for a PA denial before submitting documentation adds 1–3 weeks to the process. A proactive approach includes:

• Document BMI clearly: ≥30 kg/m² for obesity, or ≥27 kg/m² with at least one weight-related comorbidity (hypertension, dyslipidemia, type 2 diabetes, obstructive sleep apnea, PCOS, etc.)
• Document prior treatment: Record history of lifestyle modification (dietary counseling, exercise programs). Most plans require evidence of prior attempts at non-pharmacological weight management.
• Use a Letter of Medical Necessity: Lilly provides a template LOMN through the Foundayo HCP portal that can speed up the PA process.

If your practice uses electronic PA tools (CoverMyMeds, PA Hub, etc.), check whether Foundayo criteria have been added yet — it may not be in all systems as of mid-2026.

Step 3: Set Patient Expectations About Pharmacy Availability

A brief conversation at the point of prescribing can prevent several follow-up phone calls to your office. Patients should know:

• Their usual pharmacy may not have Foundayo yet — this is normal for a newly launched drug
• They should ask the pharmacy if it can special-order Foundayo (usually 1–3 business days)
• LillyDirect and Amazon Pharmacy are reliable alternatives if the local pharmacy doesn't have it
• They can use medfinder to have pharmacies called on their behalf to find stock near them

Step 4: Know the Self-Pay Pricing Bridge

If insurance approval is pending and a patient wants to start treatment, transparent self-pay pricing through LillyDirect gives patients a predictable bridge option. Costs are:

• 0.8 mg (starter): $149/month
• 2.5 mg: $199/month
• 5.5 mg–17.2 mg: $299/month (refill within 45 days required for the two highest doses)

If insurance later approves coverage, patients can transition to using their insurance with the Foundayo Savings Card ($25/month for commercially insured patients). This self-pay bridge strategy prevents treatment gaps while PA is being processed.

Step 5: Have a Backup Plan Ready

Not every patient can or will use LillyDirect. For patients where Foundayo access is a persistent barrier, having a backup plan discussed at the initial visit is valuable. Injectable GLP-1 alternatives — Zepbound (tirzepatide) or Wegovy (semaglutide) — have more established pharmacy supply chains and may be more readily available locally. Review your Foundayo alternatives options with patients who have needle aversion barriers to understand whether that's truly a limiting factor or a preference that can be worked through.

A Practical Checklist for Prescribing Foundayo

1. Confirm no contraindications (MTC history, MEN2, severe hepatic impairment)
2. Check for CYP3A4 drug interactions (especially ritonavir, carbamazepine, simvastatin)
3. Counsel on oral contraceptive backup method
4. Route prescription to LillyDirect (NPI: 1912889320) or Amazon Pharmacy
5. Proactively submit prior authorization with BMI documentation and comorbidity list
6. Advise patient about self-pay cost bridge ($149–$299/month via LillyDirect)
7. Share medfinder with patients who prefer a local retail pharmacy
8. Counsel on slow-titration adherence to minimize GI side effects

Bottom Line for Prescribers

The most important steps are: route the prescription to LillyDirect, submit prior auth proactively, and set expectations about pharmacy availability. For practices with a high volume of GLP-1 prescribing, creating a standard patient handout about these steps can significantly reduce staff burden from follow-up calls. medfinder is a useful tool to point patients toward when local retail pharmacy access is a priority for them.